BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 155286)

  • 21. Combined effect of an anticholinergic drug ipratropium bromide and disodium cromoglycate in exercise induced asthma.
    Rasmussen FV; Madsen L; Bundgaard A
    Scand J Respir Dis Suppl; 1979; 103():159-62. PubMed ID: 155292
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical pharmacology and toxicology of ipratropium bromide.
    Cugell DW
    Am J Med; 1986 Nov; 81(5A):18-22. PubMed ID: 2947457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacology and toxicology of a new tropane alkaloid derivative.
    Engelhardt A; Klupp H
    Postgrad Med J; 1975; 51(7 SUPPL):82-5. PubMed ID: 134361
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of anticholinergic drugs in nocturnal asthma.
    Hughes DT
    Postgrad Med J; 1987; 63 Suppl 1():47-51. PubMed ID: 2962074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacology of the anticholinergic bronchospasmolytic agent flutropium bromide.
    Bauer R; Fügner A
    Arzneimittelforschung; 1986 Sep; 36(9):1348-52. PubMed ID: 2431695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of ipratropium bromide on ciliary action (author's transl)].
    Nakhosteen JA; Wichtmann G; Petro W; Konietzko N
    Prax Klin Pneumol; 1980 Sep; 34(9):570-4. PubMed ID: 6450411
    [No Abstract]   [Full Text] [Related]  

  • 27. Combined treatment with ipratropium bromide and beta-2-adrenoceptor agonists in childhood asthma.
    Bratteby LE; Foucard T; Lönnerholm G
    Eur J Respir Dis; 1986 Apr; 68(4):239-47. PubMed ID: 2874047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of anatomical and pharmacological vagal nerve blockade on the action of vasoactive substances in the airway and circulatory system in anesthetized dogs].
    Shimizu K; Kuratomi Y; Ishihara T; Matsuoka R; Kitamura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jun; 25(6):613-9. PubMed ID: 2960843
    [No Abstract]   [Full Text] [Related]  

  • 29. Bronchoconstriction by nebulized metabisulfite solutions (SO2) and its modification by ipratropium bromide.
    Seale JP; Temple DM; Tennant CM
    Ann Allergy; 1988 Sep; 61(3):209-13. PubMed ID: 2970816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of oxitropium bromide and ipratropium bromide in asthma.
    Peel ET; Anderson G; Cheong B; Broderick N
    Eur J Respir Dis; 1984 Feb; 65(2):106-8. PubMed ID: 6230249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.
    Gavaldà A; Miralpeix M; Ramos I; Otal R; Carreño C; Viñals M; Doménech T; Carcasona C; Reyes B; Vilella D; Gras J; Cortijo J; Morcillo E; Llenas J; Ryder H; Beleta J
    J Pharmacol Exp Ther; 2009 Nov; 331(2):740-51. PubMed ID: 19710368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of methoxamine-induced bronchoconstriction by ipratropium bromide and disodium cromoglycate in asthmatic subjects.
    Black J; Vincenc K; Salome C
    Br J Clin Pharmacol; 1985 Jul; 20(1):41-6. PubMed ID: 2992563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of ipratropium bromide in obstructive lung disease.
    Mann KV; Leon AL; Tietze KJ
    Clin Pharm; 1988 Sep; 7(9):670-80. PubMed ID: 2977109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of inhaled ipratropium bromide on tracheal mucociliary transport in bronchial asthma.
    Bell JA; Bluestein BM; Danta I; Wanner A
    Mt Sinai J Med; 1984 Apr; 51(2):215-7. PubMed ID: 6233486
    [No Abstract]   [Full Text] [Related]  

  • 35. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis.
    Pakes GE; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1980 Oct; 20(4):237-66. PubMed ID: 6448137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiallergic asthma effect of ipatropium bromide (Sch 1000) in dogs (author's transl)].
    Yamatake Y; Sasagawa S; Yanaura S; Okamiya Y
    Nihon Yakurigaku Zasshi; 1977 Oct; 73(7):785-91. PubMed ID: 145994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose effects of inhaled ipratropium bromide on the impedance of the respiratory system in normal subjects.
    Wesseling GJ; Vonk JM; Greve LH; Wouters EF
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):33-8. PubMed ID: 2137435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ipratropium bromide (atrovent) inhalation in chronic bronchitis.
    Kashyap S; Jindal SK; Malik SK
    Indian J Chest Dis Allied Sci; 1985; 27(3):137-40. PubMed ID: 2943673
    [No Abstract]   [Full Text] [Related]  

  • 40. The protective effect of ipratropium bromide aerosol against bronchospasm induced by hyperventilation and the inhalation of allergen, methacholine and histamine.
    Clarke PS; Jarrett RG; Hall GJ
    Ann Allergy; 1982 Mar; 48(3):180-3. PubMed ID: 6461281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.